Hans van Houte

Director of Finance/CFO at NURIX THERAPEUTICS, INC.

Net worth: 1 M $ as of 2024-03-30

58 year

Health Technology

Consumer Services

Hans van Houte active positions

Companies	Position	Start	End
NURIX THERAPEUTICS, INC.	Director of Finance/CFO	2016-02-29	-

Companies	Position	Start	End
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-	-
Igenica Biotherapeutics, Inc. Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA.	Director of Finance/CFO	2010-12-31	-
Bionation LLC	Corporate Officer/Principal	-	-
VERTEX PHARMACEUTICALS INCORPORATED	Comptroller/Controller/Auditor	-	-
VERTEX PHARMACEUTICALS INCORPORATED	Treasurer	-	-

Babson College

Undergraduate Degree

International

United States

Operational

Director of Finance/CFO	2
Corporate Officer/Principal	2
Comptroller/Controller/Auditor	1

Sectoral

Health Technology	5
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
NURIX THERAPEUTICS, INC.	Health Technology

Private companies	3
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.	Health Technology
Igenica Biotherapeutics, Inc. Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA.	Health Technology
Bionation LLC